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Open access under CC BYDepression is associated with the development of the metabolic syndrome, and both depression and met-
abolic syndrome are associated with markers of systemic inﬂammation, such as C-reactive protein (CRP).
We examined associations between affective status in adolescence and adulthood, and the metabolic syn-
drome at age 53 years in a large representative British birth cohort. We also investigated whether two
CRP gene polymorphisms (rs1205 and rs3093068) were associated with affective status and the meta-
bolic syndrome, and whether the association between affective status and the metabolic syndrome
was modiﬁed by these CRP polymorphisms. Women, but not men, with emotional problems in adoles-
cence were more likely to have the metabolic syndrome (OR = 1.53, 95% CI: 1.04, 2.26), although this
sex difference was not statistically signiﬁcant (p = 0.22). The CRP SNPs were not associated with affective
status or the metabolic syndrome, but the association of adolescent emotional problems with the meta-
bolic syndrome was stronger in those who were homozygous for the major allele (C) of rs1205 (OR = 1.83,
95% CI: 1.17, 2.86) than in carriers of the T allele (OR = 1.01, 95% CI: 0.66, 1.55) (p = 0.05 for gene by affec-
tive status interaction). This interaction was stronger when considering adolescent emotional problems
as a continuous variable (p = 0.003). Adolescent emotional problems play an important role in the devel-
opment of the metabolic syndrome later in life, particularly in those homozygous for the major allele of
CRP rs1205. These ﬁndings may highlight new ways of identifying people with emotional problems at
high risk of developing the metabolic syndrome, which is of great importance for the management of
the physical health of these patients.
 2011 Elsevier Inc. Open access under CC BY license. 1. Introduction
The association between depression and the metabolic syn-
drome has assumed greater public health importance due to the
rapidly increasing prevalence of these disorders during the past
two decades (British Nutrition Foundation, 2004; Ford et al.,
2002; World Health Organization, 2008). All relevant longitudinal
studies suggest a higher incidence of the metabolic syndrome
and/or its components (high waist circumference, high triglyceride
level, low HDL level, high blood pressure, and high glucose level)
among those with depressive symptoms (Raikkonen et al., 2002,
2007; Goldbacher et al., 2009; Pulkki-Raback et al., 2009; Vaccari-
no et al., 2008; Vanhala et al., 2009; Viinamaki et al., 2009), even if
different deﬁnitions for the metabolic syndrome were used (Expert
Panel on Detection, Evaluation, and Treatment of High Blood
Cholesterol in Adults, 2001; Grundy et al., 2004). Much less atten-Lifelong Health and Ageing,
n WC1B 5JU, UK. Fax: +44
sina).
 license. tion, however, has been paid to the association between anxiety
and the metabolic syndrome, with the few existing cross-sectional
studies reporting mixed ﬁndings (Carroll et al., 2009; Dunbar et al.,
2008).
So far, the biological mechanisms underlying the association
between depression and anxiety and later metabolic syndrome re-
main poorly understood. One biological factor receiving increased
attention as a potential mechanism for this association is inﬂam-
mation. C-reactive protein (CRP) is a non-speciﬁc marker of sys-
temic inﬂammation. Its concentration rises as much as 2000-fold
during the ﬁrst 24–48 h after the onset of tissue injury or inﬂam-
mation. Higher CRP plasma levels have been shown to be associ-
ated with both the metabolic syndrome (Devaraj et al., 2009) and
depression (Raison et al., 2006; Gimeno et al., 2009; Howren
et al., 2009) and anxiety (Bankier et al., 2009; Pitsavos et al.,
2006), although some studies failed to conﬁrm these associations
(Douglas et al., 2004; O’Donovan et al., 2010; Whooley et al.,
2007). Among the possible reasons for these inconsistent ﬁndings
is the potential confounding of the relationship by factors such
as lifestyle and socioeconomic conditions. Genetic studies have
the potential to shed light on the role of CRP in the relationship
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since genes inﬂuencing CRP levels will not be inﬂuenced by these
potential confounding factors. It has been estimated that the inter-
individual variability in blood CRP level is 35–52% heritable (Pan-
kow et al., 2001; MacGregor et al., 2004) and certain single
nucleotide polymorphisms (SNPs) of the CRP gene have been found
to strongly inﬂuence the blood level of CRP (Kolz et al., 2008; Al-
meida et al., 2009; Lee et al., 2009). Two CRP SNPs, rs3093068
and rs1205, have been associated with variation in CRP level, with
the C allele of rs3093068 and the C allele of rs1205 being associ-
ated with higher level of plasma CRP (Kolz et al., 2008; Halder
et al., 2010).
To date, only a few studies have investigated CRP variations in
relation to the metabolic syndrome, with some providing null re-
sults (Evrim et al., 2009; Timpson et al., 2005), and the most recent
reporting a signiﬁcant association (Hsu et al., 2010). Similarly, only
two studies have evaluated associations between CRP polymor-
phisms and depression: one study reported a signiﬁcant associa-
tion between CRP rs1205 polymorphism and clinically signiﬁcant
depression in men (Almeida et al., 2009), while another found no
effect of three CRP polymorphisms or haplotypes on depressive
scores (Halder et al., 2010).
To the best of our knowledge, no studies have tested the role of
CRP polymorphisms in the relationship between affective status
and the metabolic syndrome or considered whether the CRP gene
modiﬁes risk for metabolic syndrome in those who have affective
symptoms, even though gene-environment interactions are likely
to contribute to a complex trait such as metabolic syndrome. Fur-
ther, the CRP gene has been found to modify the relationship be-
tween depressive symptoms and circulating CRP level (Halder
et al., 2010) suggesting the possibility of such CRP gene by depres-
sion interactions in relation to risk of the metabolic syndrome.
In the current study, we hypothesize that the CRP gene is an
important candidate gene for understanding the affective status–
metabolic syndromeassociation. Itmaybe involved in plausiblebio-
logical pathways for each of these conditions. Alternatively, the ge-
netic effect may represent an altered predisposition to the
metabolic syndrome in those who have affective symptoms. The
aim of this study, using data from the British 1946 birth cohort, is
to test: (1) whether emotional problems in adolescence and adult-
hood are associated with the metabolic syndrome in midlife; (2)
whether twoCRPpolymorphisms, rs1205and rs3093068, are associ-
ated with the metabolic syndrome and whether they are associated
with adolescent emotional problems and adult affective symptoms;
(3)whether anyassociationbetween theCRPgeneand themetabolic
syndrome is mediated through affective status; and (4) whether
there is an interaction between affective status and CRP genetic vari-
ants in relation to risk of the metabolic syndrome.2. Methods
2.1. Study participants
The Medical Research Council (MRC) National Survey of Health
and Development (NSHD) (also known as the British 1946 birth co-
hort) initially consisted of a stratiﬁed sample of 5362 children born
within marriage in England, Scotland and Wales during one week
in March 1946. The cohort has been studied on 21 occasions since
birth, most recently in 1999 when cohort members were aged
53 years, when sample size was 3035. At age 53 years the respond-
ing sample remained reasonably representative of the British born
population of the same age (Wadsworth et al., 2006).2.2. Teacher-rated adolescent emotional problems
Assessment of adolescent emotional problems was based on
questionnaires completed by teachers when survey members were
aged 13 and 15 years, describing personality, behaviour, and mood
(Rutter, 1967). These questionnaires have previously been sub-
jected to factor analysis. Items that loaded onto the emotional
problems (depression and anxiety) factor were ‘‘timid child,’’
‘‘rather frightened of rough games,’’ ‘‘extremely fearful,’’ ‘‘always
tired and washed out,’’ ‘‘usually gloomy and sad,’’ ‘‘avoids atten-
tion,’’ ‘‘very anxious,’’ ‘‘unable to make friends,’’ ‘‘difﬁdent about
competing,’’ ‘‘frequently daydreams in class,’’ and ‘‘becomes un-
duly miserable or worried in response to criticism’’ (Colman
et al., 2007; van Os et al., 1997). Cronbach’s alpha was calculated
for the scale at both ages 13 and 15, with scores of 0.68 and
0.71, respectively, indicating that the scale was reliable.
Adolescents were considered to have emotional problems if
they scored above the 88th percentile on the factor. The 88th per-
centile was chosen because a prevalence of 12% corresponds to re-
ported prevalence of adolescent affective disorder (Ofﬁce of
Applied Studies, 2005; Costello et al., 1996). It has previously been
shown that adolescents who had emotional problems at both ages
13 and 15 years had a signiﬁcantly higher risk of mental disorder at
ages 36, 43, or 53 years. They were also more likely than adoles-
cents without emotional problems to have self-reported ‘‘nervous
trouble’’ and to have been treated for psychiatric disorder during
adulthood (Colman et al., 2007). We decided to use the binary var-
iable for adolescent emotional problems in analyses in order to
make results comparable with analyses using the measure of affec-
tive symptoms at age 36 years, and because of our interest in the
effect of the more clinical symptoms. We also repeated all analyses
with the continuous measure of adolescent emotional problems.
2.3. Adult affective symptoms
Frequency and severity of affective symptoms (depression and
anxiety) were assessed in adulthood, using the Present State Exam-
ination (PSE) (Wing et al., 1974) at age 36 years. A shortened ver-
sion of the PSE was administered by trained nurses to obtain
standardised interview ratings of low mood, anxiety, and phobia
symptoms in reference to one month prior to the interview. A com-
puter-generated, previously validated categorical variable was cre-
ated from this 48-item diagnostic assessment through an index of
deﬁnition (ID) where 5 or higher was taken as evidence of affective
symptoms (6.2% of the population).
2.4. Metabolic syndrome
During the interview at age 53 years, the research nurses mea-
sured waist circumference, blood pressure and took non-fasting
blood samples fromwhich lipids and HbA1c were obtained. We de-
ﬁned the metabolic syndrome and its components using cut-points
recommended by ATPIII8 (2001); we modiﬁed this deﬁnition to in-
clude HbA1c instead of fasting plasma glucose, data for which were
unavailable (see Langenberg et al., 2006). HbA1c is a reliable esti-
mate of usual glycaemia over the preceding 6–12 weeks and has
been shown to predict mortality continuously across the entire
population distribution in people without diabetes (Khaw et al.,
2001, 2004). Participants were classiﬁed as having the metabolic
syndrome if they met any three of the following criteria: waist cir-
cumference >102 cm for men or >88 cm for women, triglyceride le-
velP1.7 mmol/L (150 mg/dL), HDL cholesterol level <1.036 mmol/
L for men or <1.295 mmol/L for women, blood pressure level
P130/85 mm Hg, or HbA1c level in the top gender-speciﬁc quarter
of the distribution (>5.8% among both men and women). Partici-
pants taking British National Formulary (BNF)-classiﬁed antihyper-
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renin–angiotensin system, and calcium-channel blockers) or BNF-
classiﬁed diabetes medications were classiﬁed as meeting high
blood pressure and HbA1c criteria, respectively. Additional
analyses using the top quintile of HbA1c (above 5.9%), rather than
quartile, as the cut-off were carried out to assess the sensitivity of
our ﬁndings to the choice of cut-point.
2.5. SNP selection and genotyping
We investigated two single nucleotide polymorphisms (SNP) of
the CRP gene, rs1205 and rs3093068. These SNPs have been shown
to be associated with plasma CRP concentration (Halder et al.,
2010; Kolz et al., 2008). DNA was extracted and puriﬁed from
whole blood using the Puregene DNA Isolation Kit (Flowgen,
Leicestershire, UK) according to the manufacturer’s protocol. The
SNPs were typed by Source Bioscience PLC using the Applied Bio-
systems (Foster City, CA) SNPlex technology which is a based on
an Oligonucleotide Ligation Assay combined with multiplex PCR
ampliﬁcation and capillary electrophoresis. Genotyping was per-
formed using an ABI 3730xl DNA Analyser and ABI GeneMapper
v4.0 software. The integrity of the genotyping was checked by
genotyping frequency, concordance of duplicates and Hardy–
Weinberg equilibrium (HWE). The call rates for the SNPs was
>99%, with >95% concordance between duplicate samples. There
was no evidence of deviation from HWE in the total sample or in
the investigated sub-groups (p > 0.05).
2.6. Statistical analysis
We used logistic regression models to assess associations be-
tween adolescent emotional problems (at age 13–15 years), and
between adult affective symptoms (at age 36 years) and the meta-
bolic syndrome and its components (at age 53 years). In addition to
the main analyses, sensitivity analyses were carried out to investi-
gate the possibility that any relationship observed may be inﬂu-
enced by reverse causality. Given that the causal direction of the
association between affective symptoms and the metabolic syn-
drome remains unknown, it is possible that any observed relation-
ship between affective symptoms and the metabolic syndrome is
due to a pre-existing metabolic syndrome resulting in affective
symptoms. Since information to allow ascertainment of the meta-
bolic syndrome before age 53 years was not available, individuals
most likely to have early onset metabolic syndrome were excluded
from these sensitivity analyses to ensure that occurrence of affec-
tive symptoms preceded the onset of the metabolic syndrome. We
excluded those who were overweight at age 15 years when consid-
ering adolescent emotional problems, and those who had diabetes
or BMIP 30 kg/m2 at age 36 years when considering adult affec-
tive symptoms.
We then ﬁtted a model with metabolic syndrome as the out-
come with both adolescent emotional problems and adult affective
symptoms as explanatory variables. All models were adjusted for
sex. Tests were then carried out to assess whether the associations
were the same in men and women by adding a sex by affective sta-
tus interaction term in addition to the main effects of sex and affec-
tive status. In addition, analyses were carried out separately for
men and women.
Pairwise linkage disequilibrium (LD) was ascertained using the
Haploview 4.0 (Barrett et al., 2005). Linkage disequilibrium be-
tween the two investigated SNPs was low (r2 = 0.03). We therefore
chose to test separately the association between the phenotypes of
interest and each of the SNPs. Associations between each CRP gene
polymorphism and the metabolic syndrome at age 53 years, as
well as between each CRP gene polymorphisms and emotional
problems in adolescence and affective symptoms in adulthood,were tested using ﬁve different genetic models (allelic, genotype,
dominant/recessive, recessive/dominant, and additive). Each poly-
morphism was then added separately to the logistic regression
model investigating the association between affective symptoms
and the metabolic syndrome to assess whether either attenuated
the relationship. If an association between any polymorphism of
CRP gene and the metabolic syndrome was observed, we then as-
sessed whether it was mediated by adolescent emotional problems
or adult affective symptoms (MacKinnon et al., 2007).
To test for an interaction between affective status and genotype,
a multiple logistic regression model was ﬁtted with the metabolic
syndrome as the outcome and genotype (based on the dominant/
recessive genotype model), affective status and their interaction
term as predictor variables and sex as a confounding variable. Data
were managed and analysed with the statistical package Stata re-
lease 10.0 (StataCorp, College Station, TX, USA).3. Results
3.1. Descriptive statistics
Every survey member with information on affective status who
had at least one clinical measure of the metabolic syndrome at age
53 years was included in the descriptive analysis (n = 2658 with
adolescent emotional problems and 2676 with adult affective
symptoms). Table 1 shows the results of the descriptive analyses
for the metabolic syndrome components by adolescent and adult
affective status. Those with information on all clinical measures
were available for the analysis of the metabolic syndrome: there
were 2078 men and women with full information on the metabolic
syndrome status among those with information on adolescent
emotional problems, and 2105 with full information on the meta-
bolic syndrome status among those with information on adult
affective symptoms at age 36 years. The frequency of adult affec-
tive symptoms did not differ between those with and those with-
out the information on the metabolic syndrome at age 53
(p = 0.73). Those with metabolic syndrome information had
slightly lower levels of adolescent emotional problems than those
without (p = 0.06).
The genotype distributions for the CRP SNPs were similar in
men and women. For rs1205, the distribution was: 44.4% (CC),
45.1% (CT), 10.5% (TT) in men (N = 1240), and 44.5% (CC), 45.8%
(CT), 9.6% (TT) in women (N = 1237) (p for sex difference in geno-
types = 0.73, alleles = 0.67). For rs3093068, the genotype distribu-
tion was: 88.1% (CC), 11.6% (CG), and 0.3% (GG) in men
(N = 1239), and 89.7% (CC), 10.1% (CG), and 0.2% (GG) in women
(N = 1231) (p for sex difference in genotypes = 0.47, alleles = 0.24).3.2. Association between affective status and the metabolic syndrome
In the total sample, the prevalence of the metabolic syndrome
was higher in those with adolescent emotional problems (32.9%)
and in those with adult affective symptoms (34.1%) than in those
without (28.2% and 28.4%, for adolescence and adulthood, respec-
tively). The differences in prevalence were similar in both cases,
with conﬁdence intervals just including the null value of zero
(Table 1).
In women, adolescent emotional problems were associated with
higher odds of the metabolic syndrome (23.2% in those without
emotional problems versus 31.7% in those with emotional prob-
lems: OR = 1.53, 95% CI: 1.04, 2.26) (top half of Table 2). There
was a suggestion that the association may be weaker in men than
women although the test for interaction did not reach conventional
signiﬁcance levels (p = 0.22, OR for interaction = 1.44, 95% CI: 0.80,
2.59). Using the continuous measure of adolescent emotional prob-
Table 1
Numbers (%) of study participants with the metabolic syndrome or its components at age 53 by presence or absence of emotional problems in adolescence and affective
symptoms in adulthood in total sample.
Controls, N (%) Cases, N (%) Difference in prevalencea (95% CI) OR (95% CI)
Adolescence emotional problems
Metabolic syndrome 1841 (28.2) 237 (32.9) 4.7 (1.6, 11.1) 1.30 (0.98, 1.74)
High waist circumference 2333 (33.9) 307 (35.7) 1.8 (3.9, 7.5) 1.06 (0.82, 1.36)
Hypertension 2293 (68.5) 300 (69.0) 0.5 (5.1, 6.0) 1.11 (0.85, 1.44)
High HbA1c level 2046 (26.0) 263 (33.4) 7.7 (1.7, 13.7) 1.46 (1.11, 1.93)
High triglycerides level 2032 (52.5) 260 (52.3) 0.2 (6.6, 6.3) 1.10 (0.84, 1.43)
High HDL level 1889 (10.3) 245 (9.4) 1.0 (4.8, 3.0) 0.90 (0.57, 1.42)
Adult affective symptoms
Metabolic syndrome 1973 (28.4) 132 (34.1) 5.7 (2.6, 14.0) 1.41 (0.97, 2.05)
High waist circumference 2496 (34.0) 163 (40.5) 6.5 (1.3, 14.3) 1.26 (0.91, 1.74)
Hypertension 2460 (68.4) 154 (69.4) 1.0 (6.5, 8.4) 1.22 (0.85, 1.74)
High HbA1c level 2186 (27.1) 144 (27.6) 0.5 (7.0, 8.1) 1.04 (0.71, 1.51)
High triglycerides level 2163 (52.2) 149 (55.7) 3.5 (4.7, 11.8) 1.40 (0.99, 1.98)
High HDL level 2019 (10.1) 140 (10.7) 0.7 (4.6, 6.0) 1.09 (0.63, 1.91)
a Difference in prevalence of metabolic syndrome and its components between those with and without adolescent emotional problems/adult affective symptoms, %.
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one score increase, 95% CI: 1.00, 1.75), but not in men (OR = 1.12,
95% CI: 0.87, 1.46). Similarly, a higher risk of the metabolic syn-
drome was observed in women with affective symptoms at age
36 years than in those without (23.9% without affective symptoms
versus 32.6% with affective symptoms: OR = 1.54, 95% CI: 0.97,
2.46) (bottom half of Table 2). However, there was no evidence of
a statistical difference in the association between men and women
(p for sex interaction = 0.53; OR = 1.29, 95% CI: 0.59, 2.83).
Adolescent emotional problems were associated with high
HbA1c level in the total sample (OR = 1.46, 95% CI: 1.11, 1.93)
(top half of Table 1). Adult affective symptoms showed the stron-
gest relationship with high triglyceride levels (bottom half of
Table 1). For women, the associations between adolescent emo-
tional problems and all components of the metabolic syndrome,
except HDL cholesterol, are in the same direction (Table 2). Similar
consistency in the direction of most associations is also seen for
adult affective symptoms. For men, the direction and size of asso-
ciations are varied. In men, childhood emotional problems are only
associated with raised Hba1c, and adult affective problems are
strongly associated with hypertension (OR = 2.62, 95% CI 1.03–
6.69). This association was not observed in women (OR = 1.01,
95% CI 0.68–1.51) and there was evidence of a sex difference in this
relationship (p for sex interaction = 0.07; OR = 0.39, 95% CI: 0.14,
1.07) (bottom half of Table 2).
Analyses including both adolescent emotional problems and
adult affective symptoms as predictors of metabolic syndrome in
women result in slight decreases in both ORs when compared with
the unadjusted estimates. Conﬁdence intervals for both variables,
however, now include 1 suggesting that these measures may not
operate independently (adolescent emotional problems: OR =
1.46, 95% CI: 0.97, 2.18; adult affective symptoms: OR = 1.52, 95%
CI: 0.93, 2.47).
Sensitivity analysis excluding women with BMIP 25 kg/m2 at
age 15 years produced a slightly stronger association between
adolescent emotional problems and the metabolic syndrome
(OR = 1.66, 95% CI: 1.07, 2.58). The ﬁndings among men (OR =
0.96, 95% CI: 0.58, 1.57) and in a total group (OR = 1.29, 95% CI:
0.93, 1.80) remained unchanged. Thus, the association between
adolescent emotional problems and metabolic syndrome was
stronger in women than in men (p for sex interaction = 0.10;
OR = 1.73; 95% CI: 0.89, 3.36).
When we excluded those with type 2 diabetes diagnosed before
age 36 years or obesity at this age, the association between adult
affective symptoms and the metabolic syndrome remained un-
changed in women (OR = 1.54, 95% CI: 0.93, 4.33), as it did in
men (OR = 1.25, 95% CI: 0.64, 2.43), and in a total group(OR = 1.43, 95% CI: 0.95, 2.13). The association between adult affec-
tive status and metabolic syndrome did not differ between men
and women (p for sex interaction = 0.62; OR = 1.24; 95% CI: 0.54,
2.85).
Sensitivity analyses using the top quintile (HbA1c above 5.9%),
rather than the top quartile, as the cut-off for deﬁning the risk
group revealed that results were essentially unchanged.
3.3. CRP gene, affective status and the metabolic syndrome
As there were no sex differences in CRP genotype or allele dis-
tribution, and sex by genotype interactions for both affective status
and metabolic syndrome were not signiﬁcant, the analysis of
genetic associations are presented in the sample with men and
women combined. We found no associations between CRP poly-
morphisms and the metabolic syndrome or between CRP polymor-
phisms and affective status in adolescence or adulthood for both
allele and genotype models (Table 3). Similarly, no associations
were found between genotypes and the continuous measure of
adolescent emotional problems (data not shown).
Inclusion of affective status in the model of the association be-
tween CRP polymorphisms and metabolic syndrome did not inﬂu-
ence the non-signiﬁcant relationship. These ﬁndings indicate that
the relationship between CRP polymorphisms and the metabolic
syndrome cannot be mediated through affective status.
To test the interaction between the CRP polymorphisms and
affective status on risk of the metabolic syndrome, we grouped
the genotypes into binary variables according to the existing liter-
ature on the effect of these polymorphisms on plasma CRP concen-
tration (Kolz et al., 2008). For rs1205, CT and TT genotypes were
combined (dominant model for minor T allele) representing a
group with lower plasma CRP level. For rs3093068, CG and GG
genotypes were combined (dominant model for minor G allele)
representing a group with higher CRP level. There was a signiﬁcant
interaction between CRP rs1205 genotype and affective status in
adolescence (p = 0.05). Stratifying the study population by CRP
rs1205 genotype group showed that adolescent emotional prob-
lems were associated with the metabolic syndrome among CC
homozygotes (OR = 1.83, 95% CI: 1.17, 1.86) with very similar dif-
ferences in predicted probabilities for men (14.2%, 95% CI: 3.3,
25.1) and for women (12.6%, 95% CI: 2.6, 22.6), but not among T al-
lele carriers (OR = 1.01, 95% CI: 0.66, 1.55; differences in predicted
probabilities = 0.3%, 95% CI: 9.6, 10.1 for men, and = 0.02%, 95%
CI: 7.6, 8.0 for women). These results are presented in Fig. 1. A
similar, but stronger, interaction was found when using the contin-
uous measure of adolescent emotional problems (p for interac-
tion = 0.003): increased risk for metabolic syndrome was
Table 2
Associations between affective status in adolescence and adulthood, and the metabolic syndrome and its components.
Men Women
Controls, N
(%)
Cases, N
(%)
Difference in prevalencea
(95% CI)
OR
(95% CI)
Controls, N
(%)
Cases, N
(%)
Difference in prevalence
(95% CI)
OR
(95% CI)
Adolescent emotional problems
Metabolic syndrome 906
(33.3)
98
(34.7)
1.4
(8.6, 11.3)
1.06
(0.69, 1.65)
935
(23.2)
139
(31.7)
8.5
(0.03, 16.6)
1.53
(1.04, 2.26)
High waist circumference 1180
(31.7)
121
(30.3)
1.3
(10.0, 7.2)
0.94
(0.63, 1.41)
1152
(36.2)
186
(39.3)
3.1
(4.5, 10.6)
1.13
(0.83, 1.56)
Hypertension 1170
(76.5)
121
(75.4)
1.1
(9.1, 6.9)
0.94
(0.61, 1.45)
1123
(60.2)
179
(64.6)
4.4
(3.1, 12.0)
1.21
(0.87, 1.68)
High HbA1c level 1050
(26.8)
109 (36.7) 9.9
(0.5, 19.3)
1.58
(1.05, 2.39)
996
(25.1)
154
(31.6)
6.5
(1.3, 14.3)
1.38
(0.95, 1.99)
High triglyceride level 1039
(64.7)
108
(60.2)
4.5
(14.2, 5.2)
0.83
(0.55, 1.24)
993
(39.7)
152
(46.7)
7.0
(1.5, 15.5)
1.33
(0.95, 1.88)
Low HDL cholesterol
level
927
(10.5)
99
(9.1)
1.4
(7.4, 4.6)
0.86
(0.42, 1.75)
962
(10.2)
146
(9.6)
0.6
(5.7, 4.6)
0.94
(0.52, 1.69)
Adult affective symptoms
Metabolic syndrome 967
(33.1)
43
(37.2)
4.1
(10.6, 18.9)
1.20
(0.64, 2.26)
1006
(23.9)
89
(32.6)
8.7
(1.4, 18.8)
1.54
(0.97, 2.46)
High waist
circumference
1244
(31.3)
48
(31.3)
0.0
(13.4, 13.3)
0.99
(0.54, 1.86)
1252
(36.7)
115
(44.4)
7.8
(1.8, 17.2)
1.38
(0.94, 2.02)
Hypertension 1235
(76.2)
47
(89.4)
13.2
(4.0, 22.3)
2.62
(1.03, 6.69)
1225
(60.7)
107
(61.0)
0.3
(9.3, 9.8)
1.01
(0.68, 1.51)
High HbA1c level 1108
(27.2)
45
(22.2)
5.5
(17.9, 6.9)
0.75
(0.36, 1.52)
1078
(26.4)
99
(30.0)
3.6
(5.7, 13.0)
1.20
(0.76, 1.87)
High triglyceride level 1094
(63.5)
46
(71.7)
8.2
(5.1, 21.5)
1.46
(0.76, 2.80)
1069
(40.6)
103
(48.5)
7.9
(2.2, 18.0)
1.38
(0.92, 2.07)
Low HDL cholesterol
level
984
(10.7)
45
(8.9)
1.8
(10.3, 6.8)
0.82
(0.29, 2.33)
1035
(9.5)
95
(11.6)
2.1
(4.6, 8.8)
1.25
(0.65, 2.43)
a Difference in prevalence of metabolic syndrome and its components between those with and without adolescent emotional problems/adult affective symptoms,%.
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homozygous for the C allele (OR = 1.75 per one score increase, 95%
CI: 1.28, 2.41), but not for T allele carriers (OR = 0.95 per one score
increase, 95% CI: 0.72, 1.25).
There was no evidence of interactions between adolescent emo-
tional problems and CRP rs3093068 or between adult affective
symptoms and either of the CRP polymorphisms.4. Discussion
This is the ﬁrst longitudinal population-based study to investi-
gate potential genetic mechanisms underlying the associations be-
tween adolescent and adult affective status and the metabolic
syndrome. Our ﬁndings provide evidence of an association be-
tween adolescent affective status and the metabolic syndrome in
women but not in men, although this sex difference was not statis-
tically signiﬁcant. CRP gene variants were not associated with the
metabolic syndrome, but the association between adolescent emo-
tional problems and later metabolic syndrome was modiﬁed by
CRP rs1205. Adolescent emotional problems were strongly related
to the metabolic syndrome among CC homozygotes, but not among
T allele carriers of the CRP rs1205 polymorphism.
Several limitations should be taken into account when inter-
preting the present ﬁndings. The metabolic syndrome ascertain-
ment was not possible in adolescence or early adulthood, thus
we can not be certain of the direction of causality of the association
between affective symptoms and metabolic syndrome. However,
the sensitivity analyses excluding those most likely to have meta-
bolic syndrome at earlier ages, that is those overweight in adoles-
cence and those who had type 2 diabetes or high waist
circumference at age 36 years, did not signiﬁcantly alter the
strength of the associations. Moreover, there was little obesity
(BMI > 30 kg/m2) in childhood or adolescence in this cohort (7%
for girls and 3% for boys at age 15) compared with the modern pop-ulation aged 2–15 (15% of girls and 17% of boys), and the preva-
lence of the metabolic syndrome was likely to be considerably
lower than in current adolescents (The Health Survey for England,
2008).
We used teacher’s ratings of adolescent mental health, which
we acknowledge may differ from self-reported adolescent internal-
izing symptoms (Auger, 2004). The validity of the adolescent mea-
sure of emotional problems derived from teacher questionnaires is,
however, supported by several lines of evidence. First, it has been
shown that teachers may identify psychiatric problems in children
more accurately than parents or the children themselves (Kresanov
et al., 1998). Second, teacher-rated psychiatric problems more
accurately predict future psychiatric disorder than psychiatric
problems based on parent or child ratings (Sourander et al.,
2004). In the 1946 birth cohort, a strong association has been ob-
served between the teacher rating measures and adult mental
health and later use of mental health services and has previously
been used to deﬁne adolescent internalizing disorder (Colman
et al., 2007).
Although a CRP plasma level measure was not available in the
cohort, several previous studies have reported that rs1205 and
rs3093068 signiﬁcantly inﬂuence the CRP plasma level (Halder
et al., 2010; Kolz et al., 2008). SNP rs3093068 is in LD with other
CRP SNP rs3093062, which lies within an evolutionarily conserved
region of the CRP promoter and are predicted to alter a transcrip-
tion factor E box binding element (Carlson et al., 2005; Szalai
et al., 2005). Furthermore, in vitro assays have demonstrated the
functional signiﬁcance of rs3093062 in the promoter region of
CRP (Carlson et al., 2005; Szalai et al., 2005). The functional signif-
icance of rs1205 is more difﬁcult to understand. SNP rs1205 is lo-
cated distal to the 30 untranslated region of CRP and in the MLT1K
repeat (Crawford et al., 2006). It is likely that there are other poly-
morphic variants of functional importance within the gene. A bet-
ter coverage with tag SNPs would require in order capturing other
possible functional variants. However, it has been shown that there
Table 3
Associations between CRP gene polymorphisms and metabolic syndrome, and affective status in adolescence and adulthood: genotype and allele frequencies presented by
categories of presence of metabolic syndrome, adolescent emotional problems and adult affective symptoms.
rs1205 genotype distribution, N (%) rs3093068 genotype distribution, N (%)
N CC CT TT N CC CG GG
Metabolic syndrome
No 1482 668 (0.45) 670 (0.45) 144 (0.10) 1477 1312 (0.89) 161 (0.11) 4 (0.00)
Yes 618 272 (0.44) 282 (0.46) 64 (0.10) 616 545 (0.88) 70 (0.11) 1 (0.01)
p value (genotype model) 0.86 0.89
p value (allele model) 0.59 0.88
Adolescent emotional problems
No 1976 878 (0.44) 897 (0.45) 201 (0.11) 1971 1757 (0.89) 208 (0.10) 6 (0.01)
Yes 245 107 (0.44) 111 (0.45) 27 (0.11) 243 214 (0.88) 29 (0.12) 0 (0.00)
p value (genotype model) 0.91 0.56
p value (allele model) 0.72 0.73
Adult affective symptoms
No 2087 922 (0.44) 948 (0.45) 217 (0.11) 2081 1860 (0.89) 216 (0.10) 5 (0.01)
Yes 144 69 (0.48) 63 (0.44) 12 (0.08) 144 124 (0.86) 20 (0.14) 0 (0.00)
p value (genotype model) 0.59 0.36
p value (allele model) 0.31 0.28
Fig. 1. The effect of adolescent emotional problems on the risk of the metabolic
syndrome among CC homozygotes and T allele carriers of the CRP rs1205
polymorphism. Odds ratios are derived by logistic regression and adjusted for
sex. No AEP = no adolescent emotional problems; AEP = adolescent emotional
problems.
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the both investigated SNPs located (Eiriksdottir et al., 2009; Hage
and Szalai, 2007). So it is unlikely that haplotypes would add be-
yond the effect of the single SNPs within these regions.
We have not formally tested for population stratiﬁcation; how-
ever the 1946 birth cohort was formed before the beginning of
large-scale immigration from Commonwealth countries and is thus
entirely of white Caucasians.
Loss to follow-up and missing data are unavoidable in long run-
ning birth cohort studies such as the NSHD. At age 53 years the
NSHD remains, in most respects, representative of the British born
population of the same age (Wadsworth et al., 2006). There were
only minor differences in level of adolescent affective symptoms
and no difference in adult affective symptoms between those in-
cluded and those excluded from our analyses. To weaken the ob-
served association between adolescent emotional problems and
risk of the metabolic syndrome, ‘‘missingness’’ would have to be
more common for people with an absence of adolescent emotional
problems and higher risk for metabolic syndrome. We cannot see
any reason why this should be the case.Our study has several methodological strengths. Our study has a
40 year follow-up from initial measurement of affective status at
age 13 years, the longest follow-up for a longitudinal study of
depression and the metabolic syndrome. It therefore provides the
opportunity to explore the effect of age of onset of the mental
health problems on the metabolic syndrome later in life. Moreover,
our study has the biggest sample size (NP 2221) in comparison
with the previous epidemiological longitudinal studies of the asso-
ciation between affective symptoms and metabolic syndrome,
where the maximum number of participants is approximately
1300 participants (Vanhala et al., 2009). Despite a large number
of studies linking depression and anxiety to elevated CRP level
(Bankier et al., 2009; Howren et al., 2009; Pitsavos et al., 2006),
so far there has been only two studies investigating CRP genetic
variants in depression (Almeida et al., 2009; Halder et al., 2010),
and none investigating these CRP variants and the metabolic syn-
drome in those with affective symptoms.
The results of the present analyses are consistent with previous
longitudinal studies reporting that depression (Raikkonen et al.,
2002, 2007; Vaccarino et al., 2008; Vanhala et al., 2009; Goldbach-
er et al., 2009; Pulkki-Raback et al., 2009; Viinamaki et al., 2009) is
a risk factor for the development of the metabolic syndrome. Four
of these studies included women only (Raikkonen et al., 2002,
2007; Vaccarino et al., 2008; Goldbacher et al., 2009), and three
others included both sexes (Viinamaki et al., 2009; Pulkki-Raback
et al., 2009; Vanhala et al., 2009). The three studies including
men and women observed sex differences in the association be-
tween depression and the metabolic syndrome. Consistent with
our ﬁndings, two studies reported an association in women but
not in men (Vanhala et al., 2009; Pulkki-Raback et al., 2009), while
one study found an association in men but not in women (Viina-
maki et al., 2009). In our study signiﬁcant gender differences were
revealed for the association with one metabolic component –
hypertension; an association between higher affective symptoms
and hypertension at age 53 years was observed in men, but not
women.
There are several unique features of the metabolic syndrome in
women (Scuteri et al., 2009), and depression is twice as high in wo-
men as in men, with the rate beginning to rise rapidly in adoles-
cence. A large number of studies suggest that adolescent
emotional problems in girls, but not in boys, lead to signiﬁcant
weight gain and/or obesity during the life course (Liem et al.,
2008; Blaine, 2008). Depressed women could be at increased risk
for the metabolic syndrome through effects on adiposity, lipid
metabolism and inﬂammation (Schneider et al., 2006). These asso-
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pressed adolescent girls (Strine et al., 2008; Fulkerson et al.,
2004) and the tracking of these poor health behaviours into adult-
hood. When comparing the prevalence of metabolic syndrome in
men and women, it is women without adolescence emotional
problems who are protected against the metabolic syndrome in la-
ter in life compared with all men and women with emotional prob-
lems. This might suggest that it is better education and more
healthy lifestyles across adult life in these women that is protec-
tive. A study of longitudinal paths to the metabolic syndrome dem-
onstrated that high blood pressure was not a risk factor for the
future development of the metabolic syndrome (Scuteri et al.,
2009). This could explain why we observed an association of affec-
tive symptoms with hypertension, but not with the metabolic syn-
drome, in men. On the other hand, the previous studies could have
had insufﬁcient power to detect an association between depression
and metabolic syndrome in men since depression is less common
in men than in women.
We used a combined trait of depression and anxiety since there
is a strong comorbidity between mood and anxiety disorders
(Lewinsohn et al., 1997; Kessler et al., 2005; Essau, 2003), and since
there is evidence for an association between both disorders and the
metabolic syndrome. The multidimensional nature of affective dis-
orders may inﬂuence its relationship with the metabolic syndrome
(Watson, 2009). It is likely that some dimensions such as fatigue
may be strongly associated with this syndrome (Maloney et al.,
2010), while others (e.g., thoughts of worthlessness) may not. In
this case, using the complex trait of affective disorders may result
in a weaker relationship. Future research is required to assess
which dimensions are most strongly associated with the metabolic
syndrome.
Emerging laboratory and epidemiological data suggest that CRP
is an important plausible factor for insulin resistance, adiposity and
other features of the metabolic syndrome (Devaraj et al., 2009). For
instance, two recent studies have provided the evidence that CRP
impairs insulin signalling (D’Alessandris et al., 2007; Xu et al.,
2007). Additionally, it has been demonstrated both in vitro and
in vivo that CRP impairs endothelial vasoreactivity, and hence
could increase the risk for hypertension (Guan et al., 2009; Singh
et al., 2007). However, ﬁndings of the genetic studies investigating
the role of CRP in inﬂammatory diseases are not consistent. One
study of the CRP gene in metabolic syndrome showed no associa-
tion (Timpson et al., 2005), while the most recent study reported
a signiﬁcant association (Hsu et al., 2010). The results of two stud-
ies of CRP and obesity using a similar Mendelian randomization ap-
proach also contradict each other, with one reporting CRP is
causally and positively related to BMI in women (Bochud et al.,
2009), while another arguing that there is no evidence that higher
CRP level causes greater adiposity (Welsh et al., 2010). A Mende-
lian randomization approach does not take into account possible
gene-environmental interactions, which are most likely to contrib-
ute to such a complex trait as metabolic syndrome.
The current study provides novel evidence for a depression-by-
CRP gene interaction effect on the metabolic syndrome. Similar to
the previous study by Timpson and colleagues (Timpson et al.,
2005), our research did not ﬁnd a signiﬁcant association between
the CRP gene and the metabolic syndrome. However, we showed
an interaction between CRP rs1205 and affective status on the risk
of the metabolic syndrome. Our ﬁnding of adolescent emotional
problems being associated with elevated risk for the metabolic
syndrome only in rs1205 CC homozygotes may be linked to their
higher CRP levels. According the study by Halder et al., C allele car-
riers had a higher mean CRP level than the TT genotype (Halder
et al., 2010). Consistently with this ﬁnding, we showed that
depressive symptoms were associated with higher risk of the met-
abolic syndrome only in CC homozygotes, possibly through higherlevel of inﬂammation. The same study also reported interaction ef-
fect between three-marker haplotype (A–G–T, rs1417938–
rs1800947–rs1205) and depressive symptoms on the higher level
of CRP (Halder et al., 2010). Unfortunately, our results are not
directly comparable with these ﬁndings, since we do not have
the information on the two other SNPs. It is possible that this
three-marker haplotype, with T allele of rs1205, captures another
functional signiﬁcant variant within CRP gene.
Our ﬁndings are in line with the following hypothesis explain-
ing the association between depression and the metabolic syn-
drome: that depression dysregulates immune system pathways
in ways that promote inﬂammation and through inﬂammation
lead to higher risk of the metabolic syndrome. Recent studies have
shown that early life trauma, with or without clinical depression, is
associated with clinically signiﬁcant levels of inﬂammation in
adulthood (Danese et al., 2007; Pace et al., 2006). Stress system
activation might promote inﬂammation process through several
mechanisms: through activation of the sympathetic nervous sys-
tem, through vagal withdrawal or through the development of glu-
cocorticoid resistance associated with increased cytokine
production (Raison et al., 2006). Thus, HPA axis hyperactivity and
autonomic nervous system dysfunction could be one plausible
mechanism that explains how emotional problems in adolescence
affect the metabolic syndrome in adulthood via the inﬂammation
process (Kop and Gottdiener, 2005).
In conclusion, we ﬁnd that adolescent emotional problems are
associated with the metabolic syndrome 40 years later, in women
but not in men, although this sex difference was not statistically
signiﬁcant. We also show that a CRP polymorphism modiﬁes the
association between adolescent affective status and the metabolic
syndrome. This suggests that inﬂammatory system genes could
provide a link between depression and the metabolic syndrome
but through more complex interactions than simple associations.
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